GlideScope Groove vs. Standard GlideScope: A Non-inferiority Study

NCT ID: NCT01489605

Last Updated: 2019-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-31

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients presenting for elective surgery requiring orotracheal intubation will be randomized to being intubated with either the GlideScope Groove video-laryngoscope or the standard GlideScope video-laryngoscope.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

See above. The primary outcome is time to intubation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation, Orotracheal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GlideScope Groove

Patients will be intubated using the GlideScope Groove device. (Verathon)

Group Type EXPERIMENTAL

GlideScope Groove

Intervention Type DEVICE

Patients will be intubated using the GlideScope Groove device. (Verathon)

Control: Standard GlideScope

Control: Patients will be intubated using standard practice, a standard GlideScope (Verathon)

Group Type ACTIVE_COMPARATOR

Control: Standard GlideScope

Intervention Type DEVICE

Patients will be intubated using the standard GlideScope. (Verathon)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GlideScope Groove

Patients will be intubated using the GlideScope Groove device. (Verathon)

Intervention Type DEVICE

Control: Standard GlideScope

Patients will be intubated using the standard GlideScope. (Verathon)

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Verathon Varathon

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any adult patient booked for elective surgery requiring orotracheal intubation.

Exclusion Criteria

1. Any patient with cervical spine abnormalities.
2. Any patients with known or probable difficult airways.
3. Any patient requiring rapid sequence induction.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Western Ontario, Canada

OTHER

Sponsor Role collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Timothy Turkstra

Staff Anesthesiologist and Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Timothy Turkstra, MD, M. Eng

Role: PRINCIPAL_INVESTIGATOR

UWO

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

London Health Sciences Center University Hospital

London, Ontario, Canada

Site Status

London Health Sciences Centre Victoria Campus

London, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18477

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.